Newsroom | 17316 results

TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare’s decision to sharply limit remote patient monitoring (RPM) reimbursement beginning January 1, 2026, to heart failure and hypertensive disorders of pregnancy, is a disservice to clinicians, patients, and the healthcare system at large. It contradicts federal momentum to modernize chronic care and misrepresents the weight of current evidence on RPM’s clinical value fo...

HENDERSON, Nev.--(BUSINESS WIRE)--Corstasis Therapeutics Inc., a commercial-stage biopharmaceutical company advancing innovative outpatient therapies for cardiovascular and renal disease, today announced that it is working with Cardiovascular Logistics (CVL) to support the clinical adoption and integration of ENBUMYST™ (bumetanide nasal spray) into modern heart failure management pathways, consistent with FDA-approved use in outpatient heart failure care. The initiative is designed to improve a...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the introduction of Genesis™ Radiology Workspace, a next-generation solution designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision. At the center of this innovation is Genesis™ View, 510(k) pending2, a powerful new viewer designed to be a fast diagnostic, zero-footprint viewer – streamlining radiology workflows with the intent to enhance patient care whil...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enable...

MOUNT ROYAL, N.J.--(BUSINESS WIRE)--The American Headache Society® (AHS), a professional society of healthcare providers dedicated to the study and treatment of headache and face pain, will host the 2025 Scottsdale Headache Symposium December 4-7 in Scottsdale, Arizona. This year’s meeting brings together physicians, scientists, and advanced practitioners for an immersive educational experience designed to elevate clinical practice and enhance patient care across the spectrum of headache disord...

PHOENIX & TAYLORSVILLE, Utah--(BUSINESS WIRE)--AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease and other autoimmune conditions, today announced the completion of their previously announced merger. The transaction unites two clinicall...

WOODSTOCK, Va.--(BUSINESS WIRE)--As part of its ongoing commitment to programs supporting mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation is partnering with The Open Table, Inc. to strengthen Shenandoah County’s response to substance use disorder (SUD) among children and adolescents. Through a $750,000 grant, The Open Table has launched Strengthening Shenandoah, a collaborative initiative uniting the Shenandoah Juvenile and Domestic Relations Court, Shenandoah Cou...

ATLANTA--(BUSINESS WIRE)--ApolloMD, Georgia’s largest provider of emergency physician services, and Anthem Blue Cross and Blue Shield of Georgia, the state’s largest health insurer, have renewed their long-standing provider agreement, ensuring continued in-network access to care for Anthem members. “ApolloMD’s mission has always been centered on delivering exceptional, patient-focused care,” said Dr. Yogin Patel, MD, MBA, FACEP, Chief Executive Officer of ApolloMD. “Renewing our partnership wit...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members....

BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, Inc., the company behind SAINT®, the first and only FDA-cleared, rapid-remission therapy for Major Depressive Disorder (MDD), today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized the 2026 Hospital Outpatient Prospective Payment System (OPPS) rule, preserving the existing payment structure for its breakthrough SAINT neuromodulation therapy. This decision ensures that Medicare patients with MDD will continue...